Development asset linked to Acumen Pharmaceuticals in public FDA and regional records.
biotech · Alzheimer Disease · ABOS
Acumen Pharmaceuticals
Acumen Pharmaceuticals drug portfolio — 9 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Boston, USA HQ
66 Employees
Public company Type
ABOS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Employees
- 66
- Programs
- 4
- Drugs
- 9
- Patents
- 6
Acumen Pharmaceuticals pipeline
Portfolio lens on 9 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Acumen Pharmaceuticals drug portfolio — 9 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
florbetaben (18f)
Various (V09)Various (V09) compound in Acumen Pharmaceuticals's portfolio. Mechanism: Diagnostic agent.
- Mechanism
- Diagnostic agent
-
US regulatory status: approved. Mechanism: Diagnostic agent.
- Mechanism
- Diagnostic agent
-
US regulatory status: approved. Mechanism: Diagnostic agent.
- Mechanism
- Diagnostic agent
-
US regulatory status: approved. Mechanism: Diagnostic agent.
- Mechanism
- Diagnostic agent
-
Development asset linked to Acumen Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Acumen Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Acumen Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Acumen Pharmaceuticals in public FDA and regional records.